TY - JOUR
T1 - Submandibular salivary proteases
T2 - Lack of a role in anti-HIV activity
AU - Kennedy, S.
AU - Davis, C.
AU - Abrams, W. R.
AU - Billings, P. C.
AU - Nagashunmugam, T.
AU - Friedman, H.
AU - Malamud, D.
N1 - Copyright:
Copyright 2017 Medline is the source for the citation and abstract of this record.
PY - 1998
Y1 - 1998
N2 - Whole human saliva contains a number of proteolytic enzymes, mostly derived from white blood cells and bacteria in the oral cavity. However, less information is available regarding proteases produced by salivary glands and present in salivary secretions. In the present study, We have analyzed submandibular saliva, collected Without contaminating cells, and identified multiple proteolytic activities. These have been characterized in terms of their susceptibility to a Series of protease inhibitors. The submandibular saliva proteases were shown to be sensitive to both serine and acidic protease inhibitors. We also used protease inhibitors to determine if salivary proteolytic activity was involved in the inhibition of HIV infectivity seen when the virus is incubated with human saliva. This anti-HIV activity has been reported to occur in whole saliva and in ductal saliva obtained from both the parotid and submandibular glands, with highest levels of activity present in the latter fluid. Protease inhibitors, at concentrations sufficient to block salivary proteolytic activity in an in vitro infectivity assay, did not block the anti-HIV effects of saliva, suggesting that the salivary proteases are not responsible for the inhibition of HIV-1 infectivity.
AB - Whole human saliva contains a number of proteolytic enzymes, mostly derived from white blood cells and bacteria in the oral cavity. However, less information is available regarding proteases produced by salivary glands and present in salivary secretions. In the present study, We have analyzed submandibular saliva, collected Without contaminating cells, and identified multiple proteolytic activities. These have been characterized in terms of their susceptibility to a Series of protease inhibitors. The submandibular saliva proteases were shown to be sensitive to both serine and acidic protease inhibitors. We also used protease inhibitors to determine if salivary proteolytic activity was involved in the inhibition of HIV infectivity seen when the virus is incubated with human saliva. This anti-HIV activity has been reported to occur in whole saliva and in ductal saliva obtained from both the parotid and submandibular glands, with highest levels of activity present in the latter fluid. Protease inhibitors, at concentrations sufficient to block salivary proteolytic activity in an in vitro infectivity assay, did not block the anti-HIV effects of saliva, suggesting that the salivary proteases are not responsible for the inhibition of HIV-1 infectivity.
UR - http://www.scopus.com/inward/record.url?scp=0032223677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032223677&partnerID=8YFLogxK
U2 - 10.1177/00220345980770070601
DO - 10.1177/00220345980770070601
M3 - Article
C2 - 9663436
AN - SCOPUS:0032223677
SN - 0022-0345
VL - 77
SP - 1515
EP - 1519
JO - Journal of dental research
JF - Journal of dental research
IS - 7
ER -